Hospital
Kau Hospital
Kau Hospital was paid $4.91M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoKAU HOSPITAL
PAHALA, HI 96777
PAHALA, HI 96777
33aNPI1558441311assigned 10/16/2006
33bProvider typeCritical Access Hospital
28Total paid$4.91M
24GClaims56,725
24DCodes billed78
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Hawaii
Rank by total paid#5 of 8
Median peer was paid$4.91M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,757 | $550K | |
| 2019 | 4,282 | $504K | |
| 2020 | 3,850 | $343K | |
| 2021 | 7,019 | $607K | |
| 2022 | 9,991 | $683K | |
| 2023 | 13,614 | $963K | |
| 2024incomplete | 14,212 | $1.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 5,475 | 4,789 | $1.91M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 5,336 | 4,738 | $662K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 13% | 2,842 | 2,194 | $649K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 1,127 | 1,025 | $630K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.4% | 1,741 | 1,599 | $412K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 6,045 | 5,368 | $146K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 3,789 | 3,546 | $89K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.4% | 1,143 | 913 | $71K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 1,046 | 832 | $66K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,562 | 2,374 | $42K |
| 93356 | <1% | 1,437 | 1,176 | $37K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 962 | 868 | $25K |
66 more codes
| 81025 | <1% | 2,019 | $14K | |
| 93246 | <1% | 862 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 175 | $12K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 310 | $12K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 173 | $11K |
| 99285 | Emergency room visit (most serious) | <1% | 13 | $11K |
| 87634 | <1% | 423 | $10K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 12 | $9K |
| 92552 | <1% | 160 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,033 | $8K |
| 81003 | <1% | 4,275 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 93 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 85 | $5K |
| 51798 | <1% | 220 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 526 | $5K |
| 93296 | <1% | 260 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 270 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 526 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 33 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 164 | $3K |
| 81002 | <1% | 1,411 | $2K | |
| 93017 | <1% | 14 | $2K | |
| 73630 | <1% | 62 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 527 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,238 | $1K |
| 73562 | <1% | 30 | $1K | |
| 95886 | <1% | 38 | $929.85 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 63 | $923.46 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 20 | $889.66 |
| 73610 | <1% | 13 | $860.17 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,880 | $835.00 |
| 80305 | <1% | 119 | $738.90 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 64 | $613.28 |
| 82962 | <1% | 205 | $424.35 | |
| 80053 | Comprehensive metabolic panel | <1% | 122 | $411.92 |
| 73130 | <1% | 30 | $410.77 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 48 | $316.78 |
| 94010 | <1% | 17 | $296.14 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 637 | $204.25 |
| 80061 | Lipid panel | <1% | 19 | $195.92 |
| 81001 | <1% | 696 | $177.50 | |
| 86580 | <1% | 25 | $175.29 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 48 | $110.20 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 388 | $74.58 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 48 | $46.05 |
| 85027 | <1% | 922 | $28.20 | |
| 71045 | Radiologic examination, chest; single view | <1% | 32 | $17.41 |
| 84075 | 0% | 231 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 58 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 64 | $0.00 |
| 82040 | 0% | 231 | $0.00 | |
| 93320 | 0% | 12 | $0.00 | |
| 87077 | 0% | 13 | $0.00 | |
| 84484 | 0% | 16 | $0.00 | |
| 74022 | 0% | 13 | $0.00 | |
| 96161 | 0% | 26 | $0.00 | |
| 85007 | 0% | 526 | $0.00 | |
| 96160 | 0% | 238 | $0.00 | |
| 84460 | 0% | 231 | $0.00 | |
| 84450 | 0% | 232 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 305 | $0.00 |
| 82247 | 0% | 231 | $0.00 | |
| 84155 | 0% | 231 | $0.00 | |
| 93325 | 0% | 149 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 45 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRIS, MERILYN (ADMINISTRATOR)
Parent organizationHAWAII HEALTH SYSTEMS CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Kau Hospital | Pahala, HI | $711K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.